Crystalvue Medical Corporation (TPEX:6527)

Crystalvue Medical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	106.09	241.64	273.35	176.55	193.78	363.87
Short-Term Investments	-	-	-	-	-	89.44
Cash & Short-Term Investments	106.09	241.64	273.35	176.55	193.78	453.32
Cash Growth	-61.19%	-11.60%	54.83%	-8.89%	-57.25%	-20.09%
Accounts Receivable	156.15	187.09	124.24	160.79	110.37	97.04
Other Receivables	-	-	-	1.9	0.03	0.14
Receivables	156.15	187.09	124.24	162.69	110.4	97.18
Inventory	275.95	260.1	286.2	257	195.83	158.2
Prepaid Expenses	12.15	11.03	9.32	11.39	11.17	7.28
Other Current Assets	-	-	3.01	2	7	8.38
Total Current Assets	550.34	699.86	696.13	609.63	518.17	724.36
Property, Plant & Equipment	614.35	470.12	366.51	390.23	408.07	83.75
Long-Term Investments	3.6	3.6	3.6	3.97	3.38	3.38
Other Intangible Assets	2.91	3.9	4.82	1.73	1.03	69.49
Long-Term Deferred Tax Assets	2.47	2.47	2.01	1.81	2.16	2.08
Other Long-Term Assets	5.73	4.95	5.36	5.62	5.7	3.75
Total Assets	1,179	1,185	1,078	1,013	938.51	886.81
Accounts Payable	78.37	90.26	69.2	68.75	52.19	72.38
Accrued Expenses	45.73	47.4	38.02	35.25	-	-
Current Portion of Leases	6.91	6.76	6.01	6.38	6.2	6.03
Current Income Taxes Payable	11.92	25.15	31.2	-	-	-
Current Unearned Revenue	1.69	16.86	15.23	13.76	12.45	5.5
Other Current Liabilities	36.01	46.78	41.79	85.89	117.35	90.21
Total Current Liabilities	180.61	233.22	201.45	210.03	188.19	174.12
Long-Term Leases	6.51	11.7	19.02	25.03	31.41	37.61
Long-Term Deferred Tax Liabilities	1.47	1.47	0.9	2.26	-	-
Total Liabilities	188.59	246.39	221.37	237.32	219.61	211.74
Common Stock	254.59	254.59	254.59	242.76	242.76	242.76
Additional Paid-In Capital	215.18	215.18	212.95	200.04	200.04	200.04
Retained Earnings	534.61	482.32	407.46	372.85	304.12	260.29
Treasury Stock	-6.58	-6.58	-10.96	-33.01	-21.04	-21.04
Comprehensive Income & Other	-6.97	-6.97	-6.97	-6.97	-6.97	-6.97
Shareholders' Equity	990.82	938.53	857.06	775.66	718.9	675.08
Total Liabilities & Equity	1,179	1,185	1,078	1,013	938.51	886.81
Total Debt	13.41	18.46	25.03	31.41	37.61	43.64
Net Cash (Debt)	92.68	223.18	248.32	145.14	156.17	409.68
Net Cash Growth	-63.41%	-10.12%	71.09%	-7.06%	-61.88%	-20.88%
Net Cash Per Share	3.60	8.69	9.82	5.69	6.16	15.99
Filing Date Shares Outstanding	25.34	25.34	25.26	24.83	25.06	25.06
Total Common Shares Outstanding	25.34	25.34	25.26	24.83	25.06	25.06
Working Capital	369.73	466.65	494.68	399.6	329.98	550.24
Book Value Per Share	39.10	37.03	33.92	31.23	28.69	26.94
Tangible Book Value	987.9	934.63	852.24	773.93	717.87	605.59
Tangible Book Value Per Share	38.98	36.88	33.73	31.16	28.65	24.17
Land	312.35	312.35	312.35	312.35	312.35	-
Machinery	142.33	271.32	140.93	136.91	129.43	90.65
Leasehold Improvements	17.07	17.07	17.01	16.68	16.68	16.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.